Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Denver news in your inbox
Catch up on the most important stories affecting your hometown with Axios Denver
Des Moines news in your inbox
Catch up on the most important stories affecting your hometown with Axios Des Moines
Minneapolis-St. Paul news in your inbox
Catch up on the most important stories affecting your hometown with Axios Twin Cities
Tampa Bay news in your inbox
Catch up on the most important stories affecting your hometown with Axios Tampa Bay
Charlotte news in your inbox
Catch up on the most important stories affecting your hometown with Axios Charlotte
Massachusetts Gov. Charlie Baker. Photo: Nathan Klima for The Boston Globe via Getty Images
Massachusetts Gov. Charlie Baker wants to move closer to direct price-setting for certain high-cost drugs, CommonWealth magazine reports, citing Baker's latest budget proposal.
Why it matters: Hey, does anybody remember what became of the last big health care reform from a moderate Republican governor of Massachusetts? Did that end up catching on anywhere else?
Details: Baker proposed a three-step plan, per CommonWealth.
- First, the state would try to negotiate a lower price directly with drugmakers.
- If that fails, it would "establish a 'target value' for a specific drug using a public rate-setting process."
- If that fails, a state commission could use the bully pulpit to try to get the drugmaker to budge, or could refer the company to the state attorney general.
The big question: How would that middle step — the "public rate-setting process" — work? And what kind of teeth would it really have?
Go deeper: The drug pricing maze